132
Views
19
CrossRef citations to date
0
Altmetric
Drug Profile

Inhaled mannitol for the treatment of cystic fibrosis

&
Pages 19-26 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paula Nunes, Thomas Ernandez, Isabelle Roth, Xiaomu Qiao, Déborah Strebel, Richard Bouley, Anne Charollais, Pierluigi Ramadori, Michelangelo Foti, Paolo Meda, Eric Féraille, Dennis Brown & Udo Hasler. (2013) Hypertonic stress promotes autophagy and microtubule-dependent autophagosomal clusters. Autophagy 9:4, pages 550-567.
Read now

Articles from other publishers (18)

Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
O. I. Simonova, Yu. V. Gorinova, O. V. Vysokolova, M. A. Mukhina & E. E. Yakushina. (2022) Mannitol therapy for children with cystic fibrosis: efficacy and safety. Meditsinskiy sovet = Medical Council 16:18, pages 56-63.
Crossref
Patrick A. Flume, Elena Amelina, Cori L. Daines, Brett Charlton, Joanna Leadbetter, Alessandro Guasconi & Moira L. Aitken. (2021) Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study. Journal of Cystic Fibrosis 20:6, pages 1003-1009.
Crossref
Yoen-Ju Son, Danforth P. Miller & Jeffry G. Weers. (2021) Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics 13:9, pages 1528.
Crossref
M. Brindha, R. Shelishiyah & S. Vasanthavalli. (2020) Molecular Docking Analysis Of CFTR Inhibitors. Molecular Docking Analysis Of CFTR Inhibitors.
Shruti M. Paranjape & Peter J. MogayzelJrJr. 2020. Cystic Fibrosis. Cystic Fibrosis 199 213 .
Yu. V. Gorinova, S. A. Krasovskiy, O. I. Simonova & E. L. Amelina. (2017) Inhaled mannitol as a new mucolytic for treatment of cystic fibrosis. PULMONOLOGIYA 26:6, pages 760-765.
Crossref
Samuel A. Molina & William R. Hunt. 2017. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease 219 249 .
Jagdeep Shur, Robert Price, David Lewis, Paul M. Young, Grahame Woollam, Dilraj Singh & Stephen Edge. (2016) From single excipients to dual excipient platforms in dry powder inhaler products. International Journal of Pharmaceutics 514:2, pages 374-383.
Crossref
Mostafa Ghanei & Ali Amini Harandi. 2016. Mustard Lung. Mustard Lung 107 138 .
Hanaa Banjar & Gerhild Angyalosi. (2015) The road for survival improvement of cystic fibrosis patients in Arab countries. International Journal of Pediatrics and Adolescent Medicine 2:2, pages 47-58.
Crossref
Patrick A. Flume, Moira L. Aitken, Diana Bilton, Penny Agent, Brett Charlton, Emma Forster, Howard G. Fox, Helge Hebestreit, John Kolbe, Jonathan B Zuckerman & Brenda M. Button. (2015) Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe 11:1, pages 39-48.
Crossref
Astrid A. Reus, Wilfred J.M. Maas, Harm T. Jansen, Samuel Constant, Yvonne C.M. Staal, Jos J. van Triel & C. Frieke Kuper. (2014) Feasibility of a 3D human airway epithelial model to study respiratory absorption. Toxicology in Vitro 28:2, pages 258-264.
Crossref
Katharine Hurt & Diana Bilton. (2014) Inhaled Interventions in Cystic Fibrosis: Mucoactive and Antibiotic Therapies. Respiration 88:6, pages 441-448.
Crossref
Omar S. Usmani. (2014) New Developments in Inhaled Drugs: Within and Beyond the Lungs. Respiration 88:1, pages 1-2.
Crossref
Anneliese S. Tyne, John Gar Yan Chan, Erin R. Shanahan, Ines Atmosukarto, Hak-Kim Chan, Warwick J. Britton & Nicholas P. West. (2013) TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Vaccine 31:40, pages 4322-4329.
Crossref
Zohreh Poursaleh, Ali Amini Harandi, Ensieh Vahedi & Mostafa Ghanei. (2012) Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase. DARU Journal of Pharmaceutical Sciences 20:1.
Crossref
Maureen A. Seckel. (2012) Normal Saline and Mucous Plugging. Critical Care Nurse 32:5, pages 66-68.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.